CardioGenics Holdings Inc (CGNH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2015 | 72.61 Thousand USD | 1.05% |
| 2014 | 71.86 Thousand USD | -77.2% |
| 2013 | 315.17 Thousand USD | 11897.45% |
| 2012 | 2627.00 USD | -90.73% |
| 2011 | 28.34 Thousand USD | -32.32% |
| 2010 | 41.87 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 2.6 Million USD | 28.62% |
| 2006 | 2.02 Million USD | 5.19% |
| 2005 | 1.92 Million USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 400 Thousand USD | 0.0% |
| 2002 | 400 Thousand USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 1.66 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2016 Q1 | 378.49 Thousand USD | 421.24% |
| 2015 Q1 | 89.82 Thousand USD | 24.99% |
| 2015 Q4 | 72.61 Thousand USD | -45.75% |
| 2015 FY | 72.61 Thousand USD | 1.05% |
| 2015 Q3 | 133.84 Thousand USD | 27.44% |
| 2015 Q2 | 105.02 Thousand USD | 16.93% |
| 2014 Q4 | 71.86 Thousand USD | -86.16% |
| 2014 FY | 71.86 Thousand USD | -77.2% |
| 2014 Q1 | 368.98 Thousand USD | 17.07% |
| 2014 Q2 | 428.06 Thousand USD | 16.01% |
| 2014 Q3 | 519.08 Thousand USD | 21.27% |
| 2013 FY | 315.17 Thousand USD | 11897.45% |
| 2013 Q2 | 227.53 Thousand USD | 20161.18% |
| 2013 Q4 | 315.17 Thousand USD | 7.14% |
| 2013 Q3 | 294.16 Thousand USD | 29.28% |
| 2013 Q1 | 1123.00 USD | -57.25% |
| 2012 Q4 | 2627.00 USD | -64.93% |
| 2012 Q3 | 7490.00 USD | -48.7% |
| 2012 FY | 2627.00 USD | -90.73% |
| 2012 Q1 | 21.4 Thousand USD | -24.47% |
| 2012 Q2 | 14.59 Thousand USD | -31.8% |
| 2011 FY | 28.34 Thousand USD | -32.32% |
| 2011 Q4 | 28.34 Thousand USD | -22.85% |
| 2011 Q3 | 36.73 Thousand USD | 62.33% |
| 2011 Q2 | 22.62 Thousand USD | -37.81% |
| 2011 Q1 | 36.38 Thousand USD | -13.11% |
| 2010 FY | 41.87 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | 41.87 Thousand USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2007 Q1 | 2.35 Million USD | 7.31% |
| 2007 Q2 | 2.48 Million USD | 5.31% |
| 2007 Q4 | 1.13 Million USD | -56.57% |
| 2007 Q3 | 2.6 Million USD | 5.05% |
| 2007 FY | 2.6 Million USD | 28.62% |
| 2006 FY | 2.02 Million USD | 5.19% |
| 2006 Q4 | 2.19 Million USD | 8.34% |
| 2006 Q1 | 1.95 Million USD | 0.71% |
| 2006 Q2 | 1.96 Million USD | 0.69% |
| 2006 Q3 | 2.02 Million USD | 2.99% |
| 2005 Q4 | 1.94 Million USD | 0.72% |
| 2005 FY | 1.92 Million USD | 0.0% |
| 2005 Q2 | 1.91 Million USD | 0.0% |
| 2005 Q3 | 1.92 Million USD | 0.73% |
| 2005 Q1 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | -100.0% |
| 2004 Q1 | 400 Thousand USD | 0.0% |
| 2003 Q3 | 400 Thousand USD | 0.0% |
| 2003 Q4 | 400 Thousand USD | 0.0% |
| 2003 Q2 | 400 Thousand USD | 0.0% |
| 2003 FY | 400 Thousand USD | 0.0% |
| 2003 Q1 | 400 Thousand USD | 0.0% |
| 2002 Q4 | 400 Thousand USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | 400 Thousand USD | 0.0% |
| 2002 Q3 | 400 Thousand USD | 0.0% |
| 2002 FY | 400 Thousand USD | 0.0% |
| 2001 Q2 | - USD | -100.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q1 | 1.7 Million USD | -1.32% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 Q3 | 1.66 Million USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | 1.66 Million USD | 0.0% |
| 2000 Q4 | 1.73 Million USD | 4.11% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 96.758% |
| Arrayit Corporation | 1.07 Million USD | 93.265% |
| Atlantic International Corp. | 2.93 Million USD | 97.522% |
| Biocept, Inc. | 12.1 Million USD | 99.4% |
| Bioqual, Inc. | 3.58 Million USD | 97.976% |
| DermTech, Inc. | 54.39 Million USD | 99.867% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.985% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 98.498% |
| iMD Companies, Inc. | 1.12 Million USD | 93.517% |
| IDenta Corp. | 789.14 Thousand USD | 90.798% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 99.351% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -65.615% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 99.097% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 98.102% |
| NovelStem International Corp. | 3.57 Million USD | 97.969% |
| Optigenex Inc. | 8.94 Million USD | 99.188% |
| PharmChem, Inc. | 77.35 Thousand USD | 6.126% |
| Proteome Sciences plc | 17.15 Million USD | 99.577% |
| Response Genetics, Inc | 6.37 Million USD | 98.861% |
| Rennova Health, Inc. | 15.32 Million USD | 99.526% |
| RushNet, Inc. | 4.82 Million USD | 98.494% |
| ScreenPro Security Inc. | 207.03 Thousand USD | 64.927% |
| Stella Diagnostics Inc. | 6.2 Million USD | 98.829% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 95.966% |
| Todos Medical Ltd. | 38.34 Million USD | 99.811% |